199 related articles for article (PubMed ID: 844913)
1. Detection of cellular immunity to tumor-associated antigen(s) in mice by the macrophage spreading inhibition test.
Svoboda I; Măzuran R; Rabatić S; Silobrcić
Int J Cancer; 1977 Mar; 19(3):371-7. PubMed ID: 844913
[TBL] [Abstract][Full Text] [Related]
2. Macrophage migration inhibition with mouse tumor antigens: properties of serum and peritoneal cells during tumor growth and after tumor loss.
Halliday WJ
Cell Immunol; 1972 Jan; 3(1):113-22. PubMed ID: 5061636
[No Abstract] [Full Text] [Related]
3. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
Brannen GE; Adams JS; Santos GW
J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
[No Abstract] [Full Text] [Related]
4. Ability of delayed-type hypersensitivity reactions to distinguish tumor-associated antigens and histocompatibility antigens in soluble extracts from murine fibrosarcomas.
Kon ND; Forbes JT; Klein PA
Int J Cancer; 1976 May; 17(5):613-20. PubMed ID: 57934
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of tumor-associated immunity with a leukocyte adherence inhibition (LAI) assay.
Hellström I; Hellström KE; Shantz G
Int J Cancer; 1976 Sep; 18(3):354-61. PubMed ID: 955746
[TBL] [Abstract][Full Text] [Related]
6. In vitro detection of cell-mediated immunity to individual tumor-specific antigens of chemically induced BALB/c fibrosarcomas.
Carbone G; Colombo MP; Sensi ML; Cernuschi A; Parmiani G
Int J Cancer; 1983 Apr; 31(4):483-9. PubMed ID: 6832855
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
Vaage J; Jones RD; Brown BW
Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
[No Abstract] [Full Text] [Related]
8. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
Harmel RP; zbar B
J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
[TBL] [Abstract][Full Text] [Related]
9. Immunological induction of DNA synthesis in mouse peritoneal macrophages. An expression of cell-mediated-immunity.
More DG; Penrose JM; Kearney R; Nelson DS
Int Arch Allergy Appl Immunol; 1973; 44(5):611-30. PubMed ID: 4146747
[No Abstract] [Full Text] [Related]
10. Leukocyte adherence inhibition as measured by a radioisotopic technique for detection of cell-mediated tumor immunity.
Pierce GE; DeVald BL
Int J Cancer; 1974 Dec; 14(6):833-9. PubMed ID: 4377009
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the A/Ph.MC.S1 tumor graft rejection in syngeneic mice.
Zákány J; Jánossy T; Németh P; Chihara G; Fachet J; Petri G
Gan; 1983 Oct; 74(5):712-22. PubMed ID: 6357932
[TBL] [Abstract][Full Text] [Related]
12. Rejection of sarcoma cells at the site of an inflammatory reaction: macrophages are not the only effector cells.
Parr IB; Wheeler LE; Alexander P
Cancer Lett; 1975 Sep; 1(1):49-53. PubMed ID: 797442
[TBL] [Abstract][Full Text] [Related]
13. Specificity of cell membrane antigens in prostatic cancer.
Brannen GE; Gomolka DM; Coffey DS
Cancer Chemother Rep; 1975; 59(1):127-38. PubMed ID: 1131799
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.
Shiku H; Bean MA; Old LJ; Oettgen HF
J Natl Cancer Inst; 1975 Feb; 54(2):415-25. PubMed ID: 1113324
[TBL] [Abstract][Full Text] [Related]
15. Macrophage mediated tumor cell cytotoxicity.
Kaplan AM; Morahan PS
Ann N Y Acad Sci; 1976; 276():134-45. PubMed ID: 1071961
[TBL] [Abstract][Full Text] [Related]
16. Cellular immunity to encephalitogenic peptide in tumour-bearing mice.
Yong WK; Halliday WJ
Br J Cancer; 1982 May; 45(5):754-61. PubMed ID: 6177329
[TBL] [Abstract][Full Text] [Related]
17. Specific triggering of macrophage accumulation at the site of secondary tumor challenge in mice with concomitant tumor immunity.
Hopper KE; Nelson DS
Cell Immunol; 1979 Sep; 47(1):163-9. PubMed ID: 509531
[No Abstract] [Full Text] [Related]
18. Cell-mediated immunity against particulate and solubilized tumor-associated antigens of murine plasmacytomas detected by macrophage migration inhibition assays.
Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
Int J Cancer; 1977 Oct; 20(4):624-31. PubMed ID: 914399
[TBL] [Abstract][Full Text] [Related]
19. Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents.
Hopper KE; Harrison J; Nelson DS
J Reticuloendothel Soc; 1979 Sep; 26(3):259-71. PubMed ID: 115998
[No Abstract] [Full Text] [Related]
20. The immunospecificity of altered initial arrest patterns of circulating cancer cells in tumor-bearing mice.
Weiss L; Glaves D
Int J Cancer; 1976 Dec; 18(6):774-7. PubMed ID: 1036490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
